Evaluation of Abnormal Involuntary Movements in Parkinson’s Disease

Mapping the Progress of Alzheimer’s and Parkinson’s Disease - Advances in Behavioral Biology ◽

10.1007/978-0-306-47593-1_69 ◽

2002 ◽

pp. 403-407

Author(s):

Håkan Widner

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Abnormal Involuntary Movements ◽

Involuntary Movements

Download Full-text

Bilateral GPi DBS is useful to reduce abnormal involuntary movements in advanced Parkinson's disease patients, but its action is related to modality and site of stimulation

European Journal of Neurology ◽

10.1046/j.1468-1331.2001.00302.x ◽

2001 ◽

Vol 8 (6) ◽

pp. 579-586 ◽

Author(s):

A. Peppe ◽

M. Pierantozzi ◽

M. G. Altibrandi ◽

P. Giacomini ◽

A. Stefani ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Abnormal Involuntary Movements ◽

Advanced Parkinson’S Disease ◽

Involuntary Movements ◽

Site Of Stimulation

Download Full-text

2.447 AMPA antagonists attenuate L-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat model of Parkinson's disease

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(08)70767-3 ◽

2007 ◽

Vol 13 ◽

pp. S140

Author(s):

C. Kobylecki ◽

P. Ravenscroft ◽

A. Crossman

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Rat Model ◽

Abnormal Involuntary Movements ◽

Involuntary Movements ◽

Ampa Antagonists

Download Full-text

The 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitor Lovastatin Reduces Severity of L-DOPA-Induced Abnormal Involuntary Movements in Experimental Parkinson's Disease

Journal of Neuroscience ◽

10.1523/jneurosci.4720-07.2008 ◽

2008 ◽

Vol 28 (17) ◽

pp. 4311-4316 ◽

Author(s):

S. Schuster ◽

A. Nadjar ◽

J. T. Guo ◽

Q. Li ◽

C. Ittrich ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Reductase Inhibitor ◽

Abnormal Involuntary Movements ◽

Involuntary Movements ◽

Download Full-text

Striatal fosB Expression Is Causally Linked with l-DOPA-Induced Abnormal Involuntary Movements and the Associated Upregulation of Striatal Prodynorphin mRNA in a Rat Model of Parkinson's Disease

Neurobiology of Disease ◽

10.1006/nbdi.1999.0259 ◽

1999 ◽

Vol 6 (6) ◽

pp. 461-474 ◽

Author(s):

M. Andersson ◽

A. Hilbertson ◽

M.A. Cenci

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Rat Model ◽

Abnormal Involuntary Movements ◽

Involuntary Movements ◽

Prodynorphin Mrna

Download Full-text

RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease

Neurobiology of Disease ◽

10.1016/j.nbd.2014.06.013 ◽

2014 ◽

Vol 70 ◽

pp. 138-148 ◽

Author(s):

Wai Kin D. Ko ◽

Marie-Laure Martin-Negrier ◽

Erwan Bezard ◽

Alan R. Crossman ◽

Paula Ravenscroft

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Rat Model ◽

Abnormal Involuntary Movements ◽

Involuntary Movements

Download Full-text

2.508 The HMG-CoA reductase inhibitor lovastatin reduces incidence of L-Dopa-induced abnormal involuntary movements in experimental Parkinson's disease

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(08)70782-x ◽

2007 ◽

Vol 13 ◽

pp. S144

Author(s):

S. Schuster ◽

A. Nadjar ◽

J.T. Guo ◽

Q. Li ◽

C. Ittrich ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Reductase Inhibitor ◽

Abnormal Involuntary Movements ◽

Hmg Coa Reductase ◽

Involuntary Movements ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonist

Neuropharmacology ◽

10.1016/j.neuropharm.2021.108693 ◽

2021 ◽

pp. 108693

Author(s):

Annalisa Pinna ◽

Giulia Costa ◽

Marcello Serra ◽

Liliana Contu ◽

Micaela Morelli

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Receptor Antagonist ◽

Rat Model ◽

Receptor Agonist ◽

Abnormal Involuntary Movements ◽

Involuntary Movements ◽

A2a Receptor ◽

Combined Administration ◽

6 Hydroxydopamine

Download Full-text

Deep Brain Stimulation for Parkinson’s Disease and Involuntary Movements : Note to avoid a False-negative Indication

Japanese Journal of Neurosurgery ◽

10.7887/jcns.26.280 ◽

2017 ◽

Vol 26 (4) ◽

pp. 280-286

Author(s):

Kazumichi Yamada ◽

Naoki Shinojima ◽

Tadashi Hamasaki

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Deep Brain Stimulation ◽

Brain Stimulation ◽

False Negative ◽

Involuntary Movements ◽

Download Full-text

Parkinson's disease patients experiencing peak-dose dyskinesia redistribute involuntary movements throughout their body to improve motor control

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2019.03.016 ◽

2019 ◽

Vol 64 ◽

pp. 312-314

Author(s):

Karina Lebel ◽

Christian Duval ◽

Etienne Goubault ◽

Sarah Bogard ◽

Pierre J. Blanchet

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Motor Control ◽

Involuntary Movements ◽

Download Full-text

EFFECTS OF LESIONS IN THE PUTAMEN ON INVOLUNTARY MOVEMENTS AND RIGIDITY IN PARKINSON'S DISEASE

Journal of the American Geriatrics Society ◽

10.1111/j.1532-5415.1956.tb01168.x ◽

1956 ◽

Vol 4 (12) ◽

pp. 1309-1319 ◽

Author(s):

Mariano Torres ◽

Irving S. Cooper ◽

Nicolas Poloukhine

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Involuntary Movements

Download Full-text